What does Innomediq do?
INNOMEDIQ specializes in healthcare innovation by providing advanced solutions and services to improve patient care and streamline medical processes. The company focuses on developing digital tools and technologies that enhance the efficiency of healthcare providers. INNOMEDIQ aims to bridge the gap between medical professionals and patients through innovative approaches and data-driven insights.
- Sectors
- Wholesalers
- Signals
-
ProfitableProfitable € 2.72M
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 8.29MStrong equity provides a buffer against setbacks.
Low riskLow risk 67.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 2.92A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 2.91MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 3.90MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 15.32MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 16.9%Social debts stay manageable relative to personnel costs.
- Investments
- Cf-System 100%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
15.32M
|
€
13.29M
|
|
|
|
|
€
3.90M
|
€
3.31M
|
€
2.75M
|
€
1.99M
|
|
|
€
2.72M
|
€
2.26M
|
€
1.67M
|
€
1.42M
|
|
|
€
8.29M
|
€
5.57M
|
€
3.31M
|
€
1.64M
|
|
|
67.12%
|
48.75%
|
37.10%
|
21.59%
|
|
|
€
4.06M
|
€
5.85M
|
€
5.59M
|
€
5.96M
|
|
|
€
44K
|
€
2.03M
|
€
1.79M
|
€
453K
|
|
|
27.30
|
25.50
|
22.10
|
18.30
|
Publications 20
All publications- Doel - Rubriek Herstructurering (Fusie, Splitsing, Overdracht Vermogen, Enz...) 15/06/2026
- Ontslagen - Benoemingen 30/01/2026
- Ontslagen - Benoemingen 14/10/2025
- Ontslagen - Benoemingen 17/06/2024
- Maatschappelijke Zetel - Ontslagen - Benoemingen 01/06/2023
Frequently asked questions
Answers to the most common questions about Innomediq, based on official government data and the filed annual accounts.
What is the VAT number of Innomediq?
The VAT number of Innomediq is BE0806.491.751.
How many employees work at Innomediq?
In 2025, Innomediq employed 27.30 full-time equivalents (FTE).
When was Innomediq established?
Innomediq was founded in 18-09-2008.
What is the official address of Innomediq?
The official address of Innomediq is Liersesteenweg 173 Heist-Op-Den-Berg 2220.
What is the legal form of Innomediq?
The juridical form of Innomediq is Public limited company (NV/SA).
What is the annual revenue of Innomediq?
The revenue of Innomediq for the 2025 financial year was €15,323,244.
What does Innomediq do?
INNOMEDIQ specializes in healthcare innovation by providing advanced solutions and services to improve patient care and streamline medical processes. The company focuses on developing digital tools and technologies that enhance the efficiency of healthcare providers. INNOMEDIQ aims to bridge the gap between medical professionals and patients through innovative approaches and data-driven insights.
Is Innomediq a reliable company?
Innomediq is a registered Rechtspersoon with company number 0806.491.751 and can be verified through the official CBE database.
What is the credit limit of Innomediq?
The estimated credit limit of Innomediq is €6,915,924.
Is Innomediq still active?
Innomediq currently has the status "Normal situation" and is active.